Company registration number 09875556 (England and Wales)
POLYMATERIA LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
POLYMATERIA LIMITED
CONTENTS
Page
Statement of financial position
1
Statement of changes in equity
2
Notes to the financial statements
3 - 13
POLYMATERIA LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Non-current assets
Intangible assets
3
198,357
239,909
Property, plant and equipment
4
145,159
235,111
Investments
5
9,660
9,660
353,176
484,680
Current assets
Inventories
6
153,943
82,685
Trade and other receivables
7
855,930
832,413
Cash and cash equivalents
1,822,634
5,262,992
2,832,507
6,178,090
Current liabilities
8
(1,737,305)
(1,590,346)
Net current assets
1,095,202
4,587,744
Total assets less current liabilities
1,448,378
5,072,424
Non-current liabilities
9
(6,924,181)
(5,886,860)
Net liabilities
(5,475,803)
(814,436)
Equity
Called up share capital
11
2,334
2,232
Share premium account
40,274,199
40,190,202
Equity reserve
-
0
42,000
Convertible loan notes
2,051,024
2,051,024
Retained earnings
(47,803,360)
(43,099,894)
Total equity
(5,475,803)
(814,436)

The notes on pages 3 to 13 form part of these financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 5 June 2026 and are signed on its behalf by:
L P Davy-Martin
Director
Company registration number 09875556 (England and Wales)
POLYMATERIA LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Share capital
Share premium account
Equity reserve
Convertible loan notes
Retained earnings
Total
Notes
£
£
£
£
£
£
As restated at 31 December 2023
2,111
35,308,117
42,000
2,015,691
(35,204,769)
2,163,150
Year ended 31 December 2024
Loss and total comprehensive income as restated
-
-
-
-
(7,895,125)
(7,895,125)
Issue of share capital
11
121
4,882,085
-
-
-
4,882,206
Equity component of convertible loan notes issued in the year
-
-
-
35,333
-
0
35,333
Balance at 31 December 2024
2,232
40,190,202
42,000
2,051,024
(43,099,894)
(814,436)
Year ended 31 December 2025
Loss and total comprehensive income
-
-
-
-
(4,703,466)
(4,703,466)
Issue of share capital
11
102
83,997
-
-
-
84,099
Share based payments
-
-
(42,000)
-
-
(42,000)
Balance at 31 December 2025
2,334
40,274,199
-
0
2,051,024
(47,803,360)
(5,475,803)

The notes on pages 3 to 13 form part of these financial statements.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Polymateria Limited is a private company limited by shares incorporated in England and Wales. The registered office is First Floor, 5 Fleet Place, London, EC4M 7RD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Going concern

The company made losses during the year amounting to £4.7m. However, had net current assets of £1.1m at the reporting date. The company raised additional investment in January 2026 and February 2026, totalling £3.1m. At the date of signing, the company has cash reserves of £3.2m. The board has agreed cash flow forecasts to 30 June 2027 that show that these cash reserves are sufficient to meet its working capital requirements.true

As a result of the above, the directors consider that the company will continue as a going concern for a period of at least twelve months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis of accounting in preparing these financial statements.

1.3
Revenue

Revenue is recognised at the fair value of the consideration receivable for goods and services provided in the normal course of business, and is shown net of VAT. Revenue is recognised when the goods are delivered or the service is performed to the extent that it is probable that economic benefits will flow into the company.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life of 10 years.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents and trademarks
20% straight line
Other intangibles
25% straight line
1.7
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Office and lab equipment
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the statement of income.

1.8
Non-current investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in the statement of comprehensive income.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.9
Inventories

Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of inventories over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in the statement of comprehensive income.

1.10
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include deposits held at call with banks.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.11
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value th r ough profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
1.12
Compound instruments

The proceeds received on issue of the company's convertible debt are allocated into their liability and equity components and presented separately in the Statement of Financial Position. The amount initially attributed to the debt component equals the discounted cash flows using a market rate of interest that would be payable on a similar debt instrument that did not include an option to convert.

The difference between the net proceeds of the convertible debt and the amount allocated to the debt component is credited directly to equity and is not subsequently remeasured.

On conversion, the debt and equity elements are credited to share capital and share premium as appropriate.

Transaction costs that relate to the issue of the instrument are allocated to the liability and equity components of the instrument in proportion to the allocation of proceeds.

1.13
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

Where the company issues instruments that include an equity component, the equity element is recognised within reserves at inception and is not subsequently remeasured.

1.14
Taxation

The tax expense represents the sum of any tax payable and deferred tax.

Current tax

Tax payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the statement of comprehensive income because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. Any liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the statement of comprehensive income, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.15
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.16
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 7 -
1.17
Share-based payments

The fair value of equity-settled share based payments to employees is determined at the date of grant and is expensed on a straight-line basis over the vesting period based on the company’s estimate of shares or options that will eventually vest.

When the terms and conditions of equity-settled share-based payments at the time they were granted are subsequently modified, the fair value of the share-based payment under the original terms and conditions and under the modified terms and conditions are both determined at the date of the modification. Any excess of the modified fair value over the original fair value is recognised over the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based payment expense is not adjusted if the modified fair value is less than the original fair value.

Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.

The company has issued share options to certain key individuals. In accordance with Section 26 of FRS102, in the absence of an observable market price for the equity instruments granted, the fair value of the equity-settled share based payments have been determined by the directors at the date of grant by reference to the observable data available in respect of the company's equity instruments.

1.18
Leases - as lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.19
Government grants

Government grants are recognised at the fair value of the asset receive d or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

Government grants relating to turnover are recognised as income over the periods when the related costs are incurred. Grants relating to an asset are recognised in income systematically over the asset's expected useful life. If part of such a grant is deferred it is recognised as deferred income rather than being deducted from the asset's carrying amount.

1.20
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
24
33
3
Intangible fixed assets
Goodwill
Patents and trademarks
Other intangibles
Total
£
£
£
£
Cost
At 1 January 2025
36,000
849,051
242,397
1,127,448
Additions
-
0
67,011
-
0
67,011
At 31 December 2025
36,000
916,062
242,397
1,194,459
Amortisation and impairment
At 1 January 2025
36,000
614,009
237,530
887,539
Amortisation charged for the year
-
0
103,696
4,867
108,563
At 31 December 2025
36,000
717,705
242,397
996,102
Carrying amount
At 31 December 2025
-
0
198,357
-
0
198,357
At 31 December 2024
-
0
235,042
4,867
239,909
POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
4
Property, plant and equipment
Plant and machinery etc
£
Cost
At 1 January 2025
1,194,516
Additions
12,903
Disposals
(2,705)
At 31 December 2025
1,204,714
Depreciation and impairment
At 1 January 2025
959,405
Depreciation charged in the year
101,446
Eliminated in respect of disposals
(1,296)
At 31 December 2025
1,059,555
Carrying amount
At 31 December 2025
145,159
At 31 December 2024
235,111
5
Fixed asset investments
2025
2024
£
£
Investment in subsidiary undertakings
9,660
9,660
6
Inventories
2025
2024
£
£
Finished goods
153,943
82,685
7
Trade and other receivables
2025
2024
£
£
Amounts falling due within one year:
Trade receivables
330,575
138,248
Corporation tax recoverable
195,733
303,083
Amounts owed by group undertakings
88,941
88,897
Other receivables
240,681
302,185
855,930
832,413
POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
7
Trade and other receivables
(Continued)
- 10 -

Amounts owed by group undertakings are unsecured, interest-free and repayable on demand.

Included in other receivables are amounts falling due in more than one year totalling £40,629 (2024 - £50,699).

8
Current liabilities
2025
2024
£
£
Trade payables
562,703
654,653
Taxation and social security
149,130
59,455
Other payables
1,025,472
876,238
1,737,305
1,590,346
9
Non-current liabilities
2025
2024
£
£
Convertible loan notes
6,924,181
5,886,860

At the year end, the face value of convertible loan notes issued by the company was £6,750,104 (2024 - £6,750,104).

On 10 October 2022, £4,754,104 of convertible loan notes were issued. The notes are convertible into shares of the company upon issuance of a noteholder conversion notice or an exit event. The notes are interest free and convert upon an exit or upon certain conditions being met. The interest charged for the year is calculated by applying an effective interest rate of 17.07% to the liability component of the loan notes.

On 6 December 2024, £2,000,000 of convertible loan notes were issued. The notes are convertible into shares of the company upon issuance of a noteholder conversion notice or an exit event. The notes are interest free and convert upon an exit or upon certain conditions being met. The interest charged for the year is calculated by applying an effective interest rate of 18.70% to the liability component of the loan notes.

The net proceeds received from the issue of the convertible loan notes have been split between the financial liability element and an equity component, representing the fair value of the embedded option to convert the financial liability into equity.

The liability component is measured at amortised cost, and the difference between the carrying amount of the liability at the date of issue and the amount reported in the Statement of Financial Position represents the effective interest charged.

The equity component of the convertible loan notes has been credited to the convertible loan notes equity reserve.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 11 -
10
Share-based payment transactions

The company has granted options to certain employees to subscribe for shares in the company under the terms of both an Enterprise Management Incentive (EMI) scheme and an unapproved share option scheme. A summary of the principal terms and conditions of all options that existed during the year is as follows:

Number of share options
Weighted average exercise price
2025
2024
2025
2024
Number
Number
£
£
Outstanding at 1 January 2025
24,700
24,700
31.04
31.04
Granted
6,201
-
0
0.01
-
0
Exercised
(7,410)
0
-
0
0.01
-
Expired
(6,475)
0
-
0
79.47
-
0
Outstanding at 31 December 2025
17,016
24,700
14.82
31.04

The principal condition is that options may not be exercised after the tenth anniversary of the date of grant. In addition, all options have vesting conditions that are conditional on length of service, the company achieving specific targets, in the event of an acquisition or listing and/or achieving individual performance objectives. All options are settled through equity.

During the year, 6,201 share options were granted of which 1,826 were against Ordinary A shares, 2,450 were against Ordinary B shares, 800 were against Ordinary C2 shares and 1,125 were against Ordinary D2 shares. On exercise of these options, new shares will be issued to the option holder for the Ordinary A and B share options, with existing shares transferring from the existing shareholder to the option holder for Ordinary C2 and D2 share options.

Of the 17,016 share options outstanding at the reporting date, 2,638 have vested but have not yet been exercised. 2,378 vest based on investor specific conditions. 2,500 vest on an exit event, 1,250 vest if the company is sold at a business valuation in excess of £100m. A further 750 vest if the business valuation is in excess of £200m, and 1,500 vest if the business valuation is in excess of £300m, 3,000 vest if the business valuation is in excess of £400m, and 3,000 vest if the business valuation is in excess of £500m.

During the year, the company recognised an equity-settled share-based payment credit of £42,000 (2024 - £nil) which related to exercisable EMI share options. This was measured at fair value with reference to observable data.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 12 -
11
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary 'A' shares of 1p each
185,979
175,733
1,859
1,757
Ordinary 'B' shares of 1p each
1,904
1,904
19
19
Ordinary 'C1' shares of 1p each
4,000
4,000
40
40
Ordinary 'C2' shares of 1p each
6,000
6,000
60
60
Ordinary 'D1' shares of 1p each
4,000
4,000
40
40
Ordinary 'D2' shares of 1p each
6,000
6,000
60
60
207,883
197,637
2,078
1,976
2025
2024
2025
2024
Preference share capital
Number
Number
£
£
Issued and fully paid
Preference A Shares of 1p each
7,685
7,685
77
77
Preference B Shares of 1p each
17,857
17,857
179
179
25,542
25,542
256
256
Total equity share capital
2,334
2,232

Ordinary A Shares carry full voting rights and rights to dividends and capital distributions pari passu with B Shares and Preference shares.

Ordinary B Shares have no voting rights except on variation of class rights and rank pari passu with A Shares for dividends and capital distributions.

Ordinary C1 Shares have no general dividend rights but are entitled to a small percentage of proceeds on certain exits or special distributions and have no voting rights except on variation of class rights.

Ordinary C2 Shares have no dividend or capital distribution rights and no voting rights except on variation of class rights, but are entitled to a small percentage of proceeds on certain exits.

Ordinary D1 Shares have no general dividend rights but are entitled to a small percentage of proceeds on certain exits or special distributions and have no voting rights except on variation of class rights.

Ordinary D2 Shares have no dividend or capital distribution rights and no voting rights except on variation of class rights, but are entitled to a small percentage of proceeds on certain exits.

Preference A Shares carry full voting rights and rank ahead of Ordinary Shares on return of capital, and are entitled to arrears and accruals of dividends.

Preference B Shares carry full voting rights, have the highest priority on return of capital, are entitled to arrears and accruals of dividends, and are convertible into Ordinary A Shares under certain conditions.

During the year, 10,246 Ordinary A shares of £0.01 each were issued for a total consideration of £84,099.

In December 2025, January 2026, and February 2026, the company received total consideration of £3,603,464 in advance for the subscription of 7,096 Ordinary A shares of £0.01 each. These shares have been issued post year end.

POLYMATERIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 13 -
12
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
559,386
98,867
13
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Senior Statutory Auditor:
Ben Hughes
Statutory Auditor:
Cooper Parry Group Limited
Date of audit report:
5 June 2026
2025-12-31 2025-01-01 false false false 05 June 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity L P Davy-Martin J D Sieff M J Bolland F C J M G De Mevius S N Susman S Matta Z Y Yeo R Horne 09875556 2025-01-01 2025-12-31 09875556 2025-12-31 09875556 2024-12-31 09875556 core:NetGoodwill 2025-12-31 09875556 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 09875556 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-12-31 09875556 core:NetGoodwill 2024-12-31 09875556 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 09875556 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-12-31 09875556 core:OtherPropertyPlantEquipment 2025-12-31 09875556 core:OtherPropertyPlantEquipment 2024-12-31 09875556 core:CurrentInventories 2025-12-31 09875556 core:CurrentInventories 2024-12-31 09875556 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 09875556 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09875556 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 09875556 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 09875556 core:CurrentFinancialInstruments 2025-12-31 09875556 core:CurrentFinancialInstruments 2024-12-31 09875556 core:ShareCapital 2025-12-31 09875556 core:ShareCapital 2024-12-31 09875556 core:SharePremium 2025-12-31 09875556 core:SharePremium 2024-12-31 09875556 core:OtherReservesSubtotal 2025-12-31 09875556 core:OtherReservesSubtotal 2024-12-31 09875556 core:OtherMiscellaneousReserve 2025-12-31 09875556 core:OtherMiscellaneousReserve 2024-12-31 09875556 core:RetainedEarningsAccumulatedLosses 2025-12-31 09875556 core:RetainedEarningsAccumulatedLosses 2024-12-31 09875556 core:ShareCapital 2023-12-31 09875556 core:SharePremium 2023-12-31 09875556 core:OtherReservesSubtotal 2023-12-31 09875556 core:RetainedEarningsAccumulatedLosses 2023-12-31 09875556 core:ShareCapitalOrdinaryShareClass2 2025-12-31 09875556 core:ShareCapitalOrdinaryShareClass2 2024-12-31 09875556 core:ShareCapitalOrdinaryShareClass3 2025-12-31 09875556 core:ShareCapitalOrdinaryShareClass3 2024-12-31 09875556 core:ShareCapitalOrdinaryShareClass4 2025-12-31 09875556 core:ShareCapitalOrdinaryShareClass4 2024-12-31 09875556 core:ShareCapitalOrdinaryShareClass5 2025-12-31 09875556 core:ShareCapitalOrdinaryShareClass5 2024-12-31 09875556 core:ShareCapitalOrdinaryShares 2025-12-31 09875556 core:ShareCapitalOrdinaryShares 2024-12-31 09875556 core:ShareCapitalPreferenceShareClass1 2025-12-31 09875556 core:ShareCapitalPreferenceShareClass1 2024-12-31 09875556 core:ShareCapitalPreferenceShareClass2 2025-12-31 09875556 core:ShareCapitalPreferenceShareClass2 2024-12-31 09875556 bus:Director1 2025-01-01 2025-12-31 09875556 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 09875556 2024-01-01 2024-12-31 09875556 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 09875556 core:SharePremium 2024-01-01 2024-12-31 09875556 core:ShareCapital 2025-01-01 2025-12-31 09875556 core:SharePremium 2025-01-01 2025-12-31 09875556 core:Goodwill 2025-01-01 2025-12-31 09875556 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 09875556 core:PatentsTrademarksLicencesConcessionsSimilar 2025-01-01 2025-12-31 09875556 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 09875556 core:PlantMachinery 2025-01-01 2025-12-31 09875556 core:NetGoodwill 2024-12-31 09875556 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 09875556 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-12-31 09875556 2024-12-31 09875556 core:NetGoodwill 2025-01-01 2025-12-31 09875556 core:OtherPropertyPlantEquipment 2024-12-31 09875556 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 09875556 2023-12-31 09875556 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 09875556 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 09875556 bus:OrdinaryShareClass4 2025-01-01 2025-12-31 09875556 bus:OrdinaryShareClass5 2025-01-01 2025-12-31 09875556 bus:PreferenceShareClass1 2025-01-01 2025-12-31 09875556 bus:PreferenceShareClass2 2025-01-01 2025-12-31 09875556 bus:OrdinaryShareClass2 2025-12-31 09875556 bus:OrdinaryShareClass3 2024-12-31 09875556 bus:OrdinaryShareClass3 2025-12-31 09875556 bus:OrdinaryShareClass4 2024-12-31 09875556 bus:OrdinaryShareClass4 2025-12-31 09875556 bus:OrdinaryShareClass5 2024-12-31 09875556 bus:OrdinaryShareClass5 2025-12-31 09875556 bus:PreferenceShareClass1 2025-12-31 09875556 bus:PreferenceShareClass3 2024-12-31 09875556 bus:PreferenceShareClass2 2025-12-31 09875556 bus:PreferenceShareClass4 2024-12-31 09875556 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09875556 bus:FRS102 2025-01-01 2025-12-31 09875556 bus:Audited 2025-01-01 2025-12-31 09875556 bus:Director2 2025-01-01 2025-12-31 09875556 bus:Director3 2025-01-01 2025-12-31 09875556 bus:Director4 2025-01-01 2025-12-31 09875556 bus:Director5 2025-01-01 2025-12-31 09875556 bus:Director6 2025-01-01 2025-12-31 09875556 bus:Director7 2025-01-01 2025-12-31 09875556 bus:Director8 2025-01-01 2025-12-31 09875556 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 09875556 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP